Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

09. November 2023 07:59 ET | Quelle: Pasithea

Pasithea Therapeutics Selects PAS-003 Lead Development Candidate, a Humanized Monoclonal Antibody that Targets α5β1 Integrin for the Treatment of both Sporadic and Familial ALS

Pasithea Tx (Nasdaq: KTTA) Selects Lead Development Candidate, Humanized mAb that Targets α5β1 Integrin for Treatment of both Sporadic and Familial ALS
26. Juni 2023 13:30 ET | Quelle: Transparency Market Research

Amyotrophic Lateral Sclerosis Treatment Market to Reach US$ 594.1 Million in 2031, Expanding at a CAGR of 5.5%: TMR Report

Wilmington, Delaware, United States, June 26, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. – In 2022, the global industry was estimated to be worth $594.1 million. It is expected to...
14. April 2023 08:50 ET | Quelle: Market.Us

Amyotrophic Lateral Sclerosis Treatment Market Sales to Reach US$ 1021 Million in 2032 | CAGR of 5.6%

New York, April 14, 2023 (GLOBE NEWSWIRE) -- The global Amyotrophic Lateral Sclerosis Treatment Market was valued at US$ 600 million in 2022 and is expected to grow US$ 1021 million in 2032. Between...